hrs9531
Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy
Fujian Shengdi Pharmaceutical Co., Ltd.Phase 3
—
Rating in progress
hrs9531 in Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active